Literature DB >> 17099243

Investigation of 3 industry-wide applied storage conditions for compound libraries.

Pierre E Ilouga1, Dirk Winkler, Christian Kirchhoff, Bernd Schierholz, Julian Wölcke.   

Abstract

The appropriate storage conditions for a compound file are a crucial factor for the success of drug discovery projects. In this study, 778 highly diverse compounds dissolved in 100% DMSO were stored under 3 industry-wide accepted storage conditions, and the compound integrity was monitored for a period of 6 months. The storage conditions selected were (1) under argon at +15 degrees C, (2) under argon at -20 degrees C, and (3) under ambient atmosphere at -20 degrees C. Each sample was assessed every 4 weeks by liquid chromatography coupled to mass spectrometry (LC/MS). Based on the resulting experimental data, a statistical projection of compound integrity over a period of 4 years for each of the 3 storage conditions was generated applying a linear mixed-effects model. A moderate loss of compound integrity of 12% was calculated for storage at -20 degrees C under argon, a loss of 21% for storage at -20 degrees C under ambient atmosphere, and a strong decrease of 58% for storage at +15 degrees C under argon over this period. The initial purity of the compounds does also influence the rate of compound degradation. Compounds with an initial purity of 50% to 75% degraded faster than compounds with an initial purity of more than 75%. The results of the study enable the prediction of the point in time, when the purity of a compound population falls below a predefined threshold that would trigger the resolubilization or retirement of the compound population represented by the analyzed samples.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17099243     DOI: 10.1177/1087057106295507

Source DB:  PubMed          Journal:  J Biomol Screen        ISSN: 1087-0571


  2 in total

1.  Monitoring compound integrity with cytochrome P450 assays and qHTS.

Authors:  Ryan MacArthur; William Leister; Henrike Veith; Paul Shinn; Noel Southall; Christopher P Austin; James Inglese; Douglas S Auld
Journal:  J Biomol Screen       Date:  2009-05-29

Review 2.  Phenotypic Screening in C. elegans as a Tool for the Discovery of New Geroprotective Drugs.

Authors:  Sven Bulterijs; Bart P Braeckman
Journal:  Pharmaceuticals (Basel)       Date:  2020-07-25
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.